Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0978-2025

CODMAN CERTAS Plus Programmable Valve Inline Small Valve Only. Recall

CODMAN CERTAS Plus Programmable Valve Inline Small Valve Only. Model Number: 828810PL. Implantable device that provides constant intraventricular pressure and drainage of CSF for the management of hydrocephalus.

FDA recall Class II

Ongoing

FDA lists this Class II recall for CODMAN CERTAS Plus Programmable Valve Inline Small Valve Only.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0978-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Dec 16, 2024
FDA report date
Jan 29, 2025
Quantity in commerce
170 units
Distribution
See key details
FDA cause
Labeling Change Control

What is being recalled?

CODMAN CERTAS Plus Programmable Valve Inline Small Valve Only. Model Number: 828810PL. Implantable device that provides constant intraventricular pressure and drainage of CSF for the management of hydrocephalus.

Affected model & UDI checker

Search the exact identifiers published for Z-0978-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
828810PLCODMAN CERTAS Plus Programmable Valve Inline Small Valve Only.Check source noticeNot specified
Not specifiedCODMAN CERTAS Plus Programmable Valve Inline Small Valve Only.Check source notice10381780535881
FDA code information

UDI-DI: 10381780535881. Lot Numbers: 7416790, 7432471, 7434929, 7434930, 7438312 and 7438313.

View the original FDA recall notice

Why was this product recalled?

Potential for certain SKUs and lot numbers were distributed with the incorrect product description on the internal and external labels.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Integra Lifesciences Corp. take?

Integra LifeSciences notified consignees on about 12/16/2024 via letter. Consignees were instructed to review and understand the information provided in the letter, complete and return the provided Customer Acknowledgement Form, remove any affected units from service and quarantine them, arrange for return of affected units, and forward the notification to anyone who utilizes the affected units. Distributors were instructed to follow the same directions but also requested to notify any customers if product was further distributed, and return affected units.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology